This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
etfs: Archive
FocusShould You Buy NVIDIA as It Nears $5T Market Cap? ETFs in Focus
by Sanghamitra Saha
NVIDIA inches closer to the $5-trillion market-cap mark. Play the AI chip boom via ETFs SHOC, SMH, SMHX, SOXY & SEMI.
etfs semiconductor
AI Meets Finance: ETFs in Spotlight as PayPal-OpenAI Seal Deal
by Aparajita Dutta
PayPal's new role as ChatGPT's default wallet cements its AI-commerce leadership and draws ETF investors seeking fintech growth exposure.
etfs fin-tech
UnitedHealth Lifts EPS Outlook Despite Mixed Q3 Results: ETFs in Focus
by Aparajita Dutta
UNH posts mixed Q3 results with a revenue miss but lifts its 2025 EPS outlook, boosting interest in healthcare ETFs like IHF and XLV.
etfs
Want to Ride the Halloween Effect: ETF Strategies to Follow
by Sanghamitra Saha
It's time for the Halloween Effect! Check out ETFs like IYG, IYF, KBWB, XLV, XBI, SMH, FTXL, SPSM & VIOO that could shine from November -- April!
etfs
From Gold to Uranium: Inside the Metals Boom of 2025
by Neena Mishra
We discuss the outlook for metals and miners, which have surged this year.
etfs gold
Agricultural ETFs to Gain With U.S.-China Trade Truce on the Horizon
by Aparajita Dutta
Trade truce hopes lift agricultural ETFs like SOYB, CORN, and TAGS, signaling a potential rebound for the U.S. farm sector.
agriculture etfs
Fed Rate Decision Ahead: ETF Areas Likely to Win
by Sanghamitra Saha
Fed rate cuts in October may fuel gains in SHV, VYM, ITB, SPYG & CARZ as lower borrowing costs should favor income plays, housing, growth & autos.
etfs
Time to Buy the Dip in Gold ETFs?
by Sanghamitra Saha
The gold bullion ETF GLD lost about 5% last week. Is this a time to buy the dip in the metal?
etfs gold
The Zacks Analyst Blog Highlights VUG, IWF, IVW, SPYG and IUSG
by Zacks Equity Research
With Fed rate cuts, easing inflation and strong earnings momentum, growth ETFs like VUG, IWF and SPYG are gaining fresh investor appeal.
etfs
Biotech ETF (BBC) Hits New 52-Week High
by Sanghamitra Saha
Biotech ETF BBC just hit a 52-week high on regulatory tailwinds, Fed rate-cut hopes, and cheaper valuations.
etfs